We've found
15,024
archived clinical trials in
Infectious Disease
We've found
15,024
archived clinical trials in
Infectious Disease
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
Updated: 12/31/1969
A Rand. Trial Comp Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine, and Prednisone) in Patients With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment
Status: Enrolling
Updated: 12/31/1969
Higher Dose of Rituxan Versus Standard Doses of Rituxan With Cyclophosphamide, Vincristine, and Prednisone in Subjects With Chronic ITP
Updated: 12/31/1969
A Rand. Trial Comp Higher Doses of Rituximab (Rituxan) With Standard Doses of Rituxan in Combination With CVP (Cyclophosphamide, Vincristine, and Prednisone) in Patients With Chronic ITP Who Have Failed/Relapsed After Rituxan Treatment
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Updated: 12/31/1969
Double Umbilical Cord Blood Transplantation for Patients With Malignant and Non-Malignant Disorders
Status: Enrolling
Updated: 12/31/1969
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
Updated: 12/31/1969
Double Umbilical Cord Blood Transplantation for Patients With Malignant and Non-Malignant Disorders
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years
Updated: 12/31/1969
Immunogenicity and Safety Study of Different Formulations of GSK Biologicals' Herpes Zoster Vaccine 1437173A When Administered Twice in Adults Aged 50 Years and Older
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): Pilot Trial
Updated: 12/31/1969
Fluid Lavage of Open Wounds (FLOW): A Multi-Center, Blinded, Factorial Pilot Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
HIV/STI Prevention for Drug-Involved Couples
Updated: 12/31/1969
HIV/STI Prevention for Drug-Involved Couples
Status: Enrolling
Updated: 12/31/1969
HIV/STI Prevention for Drug-Involved Couples
Updated: 12/31/1969
HIV/STI Prevention for Drug-Involved Couples
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Use of a Loading Dose of Vancomycin in Pediatric Dosing
Updated: 12/31/1969
The Use of a Loading Dose of Intravenous Vancomycin Will Achieve Therapeutic Concentration Earlier Than Conventional Pediatric Dosing: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Use of a Loading Dose of Vancomycin in Pediatric Dosing
Updated: 12/31/1969
The Use of a Loading Dose of Intravenous Vancomycin Will Achieve Therapeutic Concentration Earlier Than Conventional Pediatric Dosing: A Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students
Updated: 12/31/1969
Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students
Status: Enrolling
Updated: 12/31/1969
Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students
Updated: 12/31/1969
Randomized Evaluation of a Multi-Component, Rights-Based Sexuality Education Initiative for High School Students
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Status: Enrolling
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Status: Enrolling
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Updated: 12/31/1969
Intrapartum Effect of Vancomycin on Rectovaginal GBS Colonization
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US
Updated: 12/31/1969
Collection and Storage of Biological Samples Obtained by Leukapheresis for the Future Study of Immune Responses Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US (A-051)
Status: Enrolling
Updated: 12/31/1969
Biological Samples Obtained by Leukapheresis Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US
Updated: 12/31/1969
Collection and Storage of Biological Samples Obtained by Leukapheresis for the Future Study of Immune Responses Induced by Two BCG Vaccinations in BCG-naïve Healthy Adults in the US (A-051)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
Updated: 12/31/1969
First in Human Study of Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis
Status: Enrolling
Updated: 12/31/1969
Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis Autoimmune Pulmonary Alveolar Proteinosis
Updated: 12/31/1969
First in Human Study of Pioglitazone Therapy of Autoimmune Pulmonary Alveolar Proteinosis
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Updated: 12/31/1969
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
Updated: 12/31/1969
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Eustachian Tube Testing in a Pressure Chamber -- Validation Study
Updated: 12/31/1969
Eustachian Tube Testing in a Pressure Chamber -- Validation
Status: Enrolling
Updated: 12/31/1969
Eustachian Tube Testing in a Pressure Chamber -- Validation Study
Updated: 12/31/1969
Eustachian Tube Testing in a Pressure Chamber -- Validation
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Updated: 12/31/1969
A Randomized, Double-blind, Placebo-controlled Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials